Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice

Author:

Gribben John G.1ORCID,Bosch Francesc2,Cymbalista Florence345,Geisler Christian H.6,Ghia Paolo78,Hillmen Peter9,Moreno Carol10,Stilgenbauer Stephan11

Affiliation:

1. Barts Cancer Institute; Queen Mary University of London; London UK

2. Department of Haematology; Vall d'Hebron University Hospital; Barcelona Spain

3. U978 Institut National de la Santé et de la Recherche Médicale; Bobigny France

4. Labex Inflamex; Université Paris 13; Sorbonne Paris Cité; Bobigny France

5. Hôpital Avicenne; Assistance Publique-Hôpitaux de Paris; Bobigny France

6. Department of Haematology; Rigshospitalet; Copenhagen Denmark

7. Strategic Research Programme on CLL; IRCCS San Raffaele Hospital; Milan Italy

8. Università Vita-Salute San Raffaele; Milan Italy

9. St James' Institute of Oncology; University of Leeds; Leeds UK

10. Department of Haematology; Hospital de la Santa Creu Sant Pau; Autonomous University of Barcelona; Barcelona Spain

11. Department of Internal Medicine III; University of Ulm; Ulm Germany

Funder

Janssen-Cilag Ltd

Publisher

Wiley

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3